LONDON — Britain’s MHRA medicine regulator is considering precautionary advice for people with a history of capillary leak syndrome but does not see a causal link with AstraZeneca’s COVID-19 vaccine after the EU said it was a rare side effect of the shot.
MHRA Chief Executive June Raine said that two of eight reports of capillary leak syndrome following AstraZeneca vaccination were in people with a history of the condition, and 40 million doses of the vaccine had been given.
“The incidence of these reports is lower than the number of cases expected to occur by chance in the absence of vaccination of this extremely rare condition and the current evidence does not suggest that …
Keep on reading: UK medicine regulator looking at capillary leak syndrome precaution for AstraZeneca shot